Celldex Therapeutics, Inc. (CLDX)

NASDAQ: CLDX · Real-Time Price · USD

20.70

-0.66 (-3.07%)

At close: Jun 9, 2025, 4:00 PM

20.71

+0.02 (0.07%)

After-hours: Jun 9, 2025, 4:56 PM EDT

Celldex Therapeutics Market Cap

Celldex Therapeutics has a market cap or net worth of $1.37 billion as of June 9, 2025. Its market cap has decreased by -44.66% in one year.

Market Cap

1.37B

Enterprise Value

672.63M

1-Year Change

-44.66%

Ranking

#2197

Market Cap Chart

Since July 23, 2003, Celldex Therapeutics's market cap has increased from $148.10M to $1.37B, an increase of 827.77%. That is a compound annual growth rate of 10.71%.

Market Cap History

Date	Market Cap	% Change
Jun 6, 2025	1.42B	-15.45%
Dec 31, 2024	1.68B	-10.56%
Dec 29, 2023	1.87B	-10.70%
Dec 30, 2022	2.10B	16.42%
Dec 31, 2021	1.80B	160.11%
Dec 31, 2020	693.20M	1,825.56%
Dec 31, 2019	36.00M	5.57%
Dec 31, 2018	34.10M	-91.17%
Dec 29, 2017	386.20M	7.76%
Dec 30, 2016	358.40M	-76.83%
Dec 31, 2015	1.55B	-5.39%
Dec 31, 2014	1.64B	-16.73%
Dec 31, 2013	1.96B	372.13%
Dec 31, 2012	415.90M	262.28%
Dec 30, 2011	114.80M	-13.10%
Dec 31, 2010	132.10M	-10.50%
Dec 31, 2009	147.60M	17.99%
Dec 31, 2008	125.10M	237.20%
Dec 31, 2007	37.10M	-62.68%
Dec 29, 2006	99.40M	-28.69%
Dec 30, 2005	139.40M	-6.44%
Dec 31, 2004	149.00M	-15.96%
Dec 31, 2003	177.30M	19.72%

View and export this data all the way back to 2003. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	693.05B
Johnson & Johnson	373.18B
AbbVie	336.04B
Novo Nordisk	332.47B
UnitedHealth Group	274.69B
Novartis AG	231.17B
Abbott Laboratories	231.02B
AstraZeneca	226.14B

Market Cap Rankings